Esophageal Diseases  >>  albumin-bound paclitaxel  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
albumin-bound paclitaxel / Generic mfg.
ACTION, NCT02273713: The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma

Completed
1/2
154
Europe
Nab-paclitaxel, Abraxane
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Celgene Corporation
Esophageal Cancer, Toxicity
03/17
03/17

Download Options